doi: 10.1097/FPC.0b013e32833eca92.
SLC19A1 pharmacogenomics summary
Affiliations
- PMID: 20811316
- PMCID: PMC2956130
- DOI: 10.1097/FPC.0b013e32833eca92
Item in Clipboard
SLC19A1 pharmacogenomics summary
Pharmacogenet Genomics.
2010 Nov.
No abstract available
Similar articles
-
Genetic markers in methotrexate treatments.Pharmacogenomics J. 2018 Dec;18(6):689-703. doi: 10.1038/s41397-018-0047-z. Epub 2018 Sep 20. Pharmacogenomics J. 2018. PMID: 30237581
-
Association between reduced folate carrier G80A polymorphism and methotrexate toxicity in childhood acute lymphoblastic leukemia: a meta-analysis.Leuk Lymphoma. 2014 Dec;55(12):2793-800. doi: 10.3109/10428194.2014.898761. Epub 2014 Apr 3. Leuk Lymphoma. 2014. PMID: 24597986
-
[Individual monitoring of thiopurine and methotrexate treatment].Ugeskr Laeger. 2005 May 16;167(20):2177-9. Ugeskr Laeger. 2005. PMID: 15987078 Danish. No abstract available.
-
The influence of genetic RFC1, MS and MTHFR polymorphisms on the risk of acute lymphoblastic leukemia relapse in children and the adverse effects of methotrexate.Adv Clin Exp Med. 2013 Jul-Aug;22(4):579-84. Adv Clin Exp Med. 2013. PMID: 23986219 Review.
-
Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases.Eur J Pharm Sci. 2017 Nov 15;109:480-485. doi: 10.1016/j.ejps.2017.09.006. Epub 2017 Sep 5. Eur J Pharm Sci. 2017. PMID: 28887233 Clinical Trial.
Cited by
-
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia.Pharmacotherapy. 2023 Mar;43(3):205-214. doi: 10.1002/phar.2779. Epub 2023 Feb 27. Pharmacotherapy. 2023. PMID: 36764694 Free PMC article.
-
Genetic Polymorphisms of Pharmacogenes among the Genetically Isolated Circassian Subpopulation from Jordan.J Pers Med. 2020 Jan 6;10(1):2. doi: 10.3390/jpm10010002. J Pers Med. 2020. PMID: 31935801 Free PMC article.
-
Structural basis of thiamine transport and drug recognition by SLC19A3.Nat Commun. 2024 Oct 2;15(1):8542. doi: 10.1038/s41467-024-52872-8. Nat Commun. 2024. PMID: 39358356 Free PMC article.
-
Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.Clin Rheumatol. 2016 Apr;35(4):879-85. doi: 10.1007/s10067-015-2917-y. Epub 2015 Mar 15. Clin Rheumatol. 2016. PMID: 25771854
-
Nucleic acid-induced inflammation on hematopoietic stem cells.Exp Hematol. 2024 Mar;131:104148. doi: 10.1016/j.exphem.2023.104148. Epub 2023 Dec 25. Exp Hematol. 2024. PMID: 38151171 Free PMC article.
References
-
- Smulders YM, Stehouwer CD. Folate metabolism and cardiovascular disease. Semin Vasc Med. 2005;5:87–97. - PubMed
-
- Prasad PD, Ramamoorthy S, Leibach FH, Ganapathy V. Molecular cloning of the human placental folate transporter. Biochem Biophys Res Commun. 1995;206:681–687. - PubMed
-
- Nguyen TT, Dyer DL, Dunning DD, Rubin SA, Grant KE, Said HM. Human intestinal folate transport: cloning, expression, and distribution of complementary RNA. Gastroenterology. 1997;112:783–791. - PubMed
-
- Wong SC, Proefke SA, Bhushan A, Matherly LH. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J Biol Chem. 1995;270:17468–17475. - PubMed
-
- Williams FM, Flintoff WF. Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J Biol Chem. 1995;270:2987–2992. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
